{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:05:35Z","timestamp":1789178735181,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"publisher","award":["FEMH-2024-C-042"],"award-info":[{"award-number":["FEMH-2024-C-042"]}],"id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH 113-E0005"],"award-info":[{"award-number":["NTUH 113-E0005"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["114-E0007"],"award-info":[{"award-number":["114-E0007"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["112-FTN0022"],"award-info":[{"award-number":["112-FTN0022"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jmii.2025.03.016","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T18:42:41Z","timestamp":1743273761000},"page":"470-478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The therapeutic impact of maximum chemotherapy possession days during three consecutive months in non-tuberculous mycobacterial lung disease: A real-world experience"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0304-4258","authenticated-orcid":false,"given":"Ping-Huai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Feng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jung","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-0850","authenticated-orcid":false,"given":"Shu-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0311-5148","authenticated-orcid":false,"given":"Chin-Chung","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Jen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2025.03.016_bib1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3201\/eid2303.161927","article-title":"Pulmonary nontuberculous mycobacteria\u2013associated deaths, ontario, Canada, 2001\u20132013","volume":"23","author":"Marras","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2025.03.016_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00798-2019","article-title":"Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study","volume":"55","author":"Jhun","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmii.2025.03.016_bib3","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1093\/cid\/ciaa1381","article-title":"Mortality and prognostic factors of nontuberculous mycobacterial infection in korea: a population-based comparative study","volume":"72","author":"Lee","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.03.016_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.03.016_bib5","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","article-title":"British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.jmii.2025.03.016_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1513\/AnnalsATS.201308-266OC","article-title":"Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study","volume":"11","author":"Miwa","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jmii.2025.03.016_bib7","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1038\/s41598-024-55135-0","article-title":"Effect of multidrug therapy on the prognosis of Mycobacterium avium complex pulmonary disease","volume":"14","author":"Ushiki","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmii.2025.03.016_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1513\/AnnalsATS.201304-085OC","article-title":"Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease","volume":"11","author":"Adjemian","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jmii.2025.03.016_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01855-2016","article-title":"Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases","volume":"49","author":"van Ingen","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmii.2025.03.016_bib10","doi-asserted-by":"crossref","first-page":"e1408","DOI":"10.1093\/cid\/ciac394","article-title":"Evaluation of Mycobacterium avium complex pulmonary disease treatment completion and adherence to ATS\/IDSA guidelines","volume":"76","author":"Ku","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.03.016_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12890-023-02460-1","article-title":"Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in The Netherlands based on medication dispensing data","volume":"23","author":"Hoefsloot","year":"2023","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jmii.2025.03.016_bib12","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.chest.2018.01.024","article-title":"Microbiologic outcome of interventions against Mycobacterium avium complex pulmonary disease: a systematic review","volume":"153","author":"Diel","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jmii.2025.03.016_bib13","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkx311","article-title":"Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease","volume":"72","author":"Pasipanodya","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2025.03.016_bib14","article-title":"The impact of nontuberculous mycobacteria species on mortality in patients with nontuberculous mycobacterial lung disease","volume":"13","author":"Wang","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmii.2025.03.016_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00170-2018","article-title":"Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement","volume":"51","author":"van Ingen","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmii.2025.03.016_bib16","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/cid\/cix517","article-title":"Treatment outcomes of Mycobacterium avium complex lung disease: a systematic review and meta-analysis","volume":"65","author":"Kwak","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.03.016_bib17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/cid\/ciaa252","article-title":"Variability in the management of adults with pulmonary nontuberculous mycobacterial disease","volume":"72","author":"Abate","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.03.016_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106025","article-title":"Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy","volume":"169","author":"Ito","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.jmii.2025.03.016_bib19","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.chest.2020.10.031","article-title":"Managing Mycobacterium avium complex lung disease with a little help from my friend","volume":"159","author":"Griffith","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jmii.2025.03.016_bib20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/17476348.2021.1887734","article-title":"A multidisciplinary approach to the management of nontuberculous mycobacterial lung disease: a clinical perspective","volume":"15","author":"Ali","year":"2021","journal-title":"Expet Rev Respir Med"},{"key":"10.1016\/j.jmii.2025.03.016_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.201408-1545OC","article-title":"Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease","volume":"191","author":"Jeong","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2025.03.016_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/14787210.2020.1720650","article-title":"Antibiotic therapy success rate in pulmonary Mycobacterium avium complex: a systematic review and meta-analysis","volume":"18","author":"Nasiri","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jmii.2025.03.016_bib23","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1093\/cid\/ciaa1267","article-title":"Reduction in expected survival associated with nontuberculous mycobacterial pulmonary disease","volume":"72","author":"Mourad","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.03.016_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1164\/rccm.202004-1418OC","article-title":"BACES score for predicting mortality in nontuberculous mycobacterial pulmonary disease","volume":"203","author":"Kim","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2025.03.016_bib25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2025.03.016_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijid.2016.03.006","article-title":"Update on pulmonary disease due to non-tuberculous mycobacteria","volume":"45","author":"Stout","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jmii.2025.03.016_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36255-w","article-title":"Predictors of developing Mycobacterium kansasii pulmonary disease within 1 year among patients with single isolation in multiple sputum samples: a retrospective, longitudinal, multicentre study","volume":"8","author":"Huang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmii.2025.03.016_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/tropicalmed7020027","article-title":"Factors associated with treatment outcome in patients with nontuberculous mycobacterial pulmonary disease: a large population-based retrospective cohort study in shanghai","volume":"7","author":"Cheng","year":"2022","journal-title":"Tropical Medicine and Infectious Disease"},{"issue":"Suppl 1","key":"10.1016\/j.jmii.2025.03.016_bib29","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jfma.2020.05.018","article-title":"Treatment of pulmonary disease caused by Mycobacterium kansasii","volume":"119","author":"Huang","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2025.03.016_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.04.020","article-title":"Impact of different subspecies on disease progression in initially untreated patients with Mycobacterium avium complex lung disease","volume":"27","author":"Pan","year":"2021","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225000787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225000787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:01:18Z","timestamp":1778522478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118225000787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1684118225000787"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2025.03.016","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic impact of maximum chemotherapy possession days during three consecutive months in non-tuberculous mycobacterial lung disease: A real-world experience","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2025.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}